These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32922110)

  • 81. Endocrine manifestations and management of Prader-Willi syndrome.
    Emerick JE; Vogt KS
    Int J Pediatr Endocrinol; 2013 Aug; 2013(1):14. PubMed ID: 23962041
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Epigenetics in Prader-Willi Syndrome.
    Mendiola AJP; LaSalle JM
    Front Genet; 2021; 12():624581. PubMed ID: 33659026
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical management of behavioral characteristics of Prader-Willi syndrome.
    Ho AY; Dimitropoulos A
    Neuropsychiatr Dis Treat; 2010 May; 6():107-18. PubMed ID: 20505842
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome.
    Kim YM; Lee YJ; Kim SY; Cheon CK; Lim HH
    Ann Pediatr Endocrinol Metab; 2020 Mar; 25(1):52-56. PubMed ID: 32252218
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prader-Willi syndrome and autism spectrum disorders: an evolving story.
    Dykens EM; Lee E; Roof E
    J Neurodev Disord; 2011 Sep; 3(3):225-37. PubMed ID: 21858456
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Social responsiveness and competence in Prader-Willi syndrome: direct comparison to autism spectrum disorder.
    Dimitropoulos A; Ho A; Feldman B
    J Autism Dev Disord; 2013 Jan; 43(1):103-13. PubMed ID: 22576167
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Health Problems in Adults with Prader-Willi Syndrome of Different Genetic Subtypes: Cohort Study, Meta-Analysis and Review of the Literature.
    Rosenberg AGW; Wellink CM; Tellez Garcia JM; Pellikaan K; Van Abswoude DH; Davidse K; Van Zutven LJCM; Brüggenwirth HT; Resnick JL; Van der Lely AJ; De Graaff LCG
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887798
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A scoping review of case law relating to support and treatment for people with Prader-Willi Syndrome.
    Murray A; Kuhn I; Gulati G; Fistein E
    Int J Law Psychiatry; 2021; 78():101733. PubMed ID: 34481216
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of Transcranial Direct Current Stimulation (tDCS) on Go/NoGo Performance Using Food and Non-Food Stimuli in Patients with Prader-Willi Syndrome.
    Poje AB; Manzardo A; Gustafson KM; Liao K; Martin LE; Butler MG
    Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33671295
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Review of Prader-Willi syndrome: the endocrine approach.
    Heksch R; Kamboj M; Anglin K; Obrynba K
    Transl Pediatr; 2017 Oct; 6(4):274-285. PubMed ID: 29184809
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The paradox of Prader-Willi syndrome revisited: Making sense of the phenotype.
    Holland A; Manning K; Whittington J
    EBioMedicine; 2022 Apr; 78():103952. PubMed ID: 35316681
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment.
    Jin DK
    Korean J Pediatr; 2012 Jul; 55(7):224-31. PubMed ID: 22844316
    [TBL] [Abstract][Full Text] [Related]  

  • 93. EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.
    Butler MG; Nelson TA; Driscoll DJ; Manzardo AM
    J Rare Disord; 2015 Sep; 3(2):. PubMed ID: 27570781
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Leptin signaling defects in a mouse model of Prader-Willi syndrome: An orphan genetic obesity syndrome no more?
    Colmers WF; Wevrick R
    Rare Dis; 2013; 1():e24421. PubMed ID: 25002992
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Tailored management of life-threatening complications related to severe obesity in a young adult with Prader-Willi syndrome.
    Kim MS; Kim J; Cho J; Cho SY; Jin DK
    Ann Pediatr Endocrinol Metab; 2022 Jun; 27(2):148-152. PubMed ID: 34670069
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The neurobiology of the Prader-Willi phenotype of fragile X syndrome.
    Muzar Z; Lozano R; Kolevzon A; Hagerman RJ
    Intractable Rare Dis Res; 2016 Nov; 5(4):255-261. PubMed ID: 27904820
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Three scenarios illustrating ethical concerns when considering bariatric surgery in obese adolescents with Prader-Willi syndrome.
    Di Pietro ML; Zaçe D
    J Med Ethics; 2020 Nov; 46(11):738-742. PubMed ID: 32341185
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
    Miller JL; Gevers E; Bridges N; Yanovski JA; Salehi P; Obrynba KS; Felner EI; Bird LM; Shoemaker AH; Angulo M; Butler MG; Stevenson D; Abuzzahab J; Barrett T; Lah M; Littlejohn E; Mathew V; Cowen NM; Bhatnagar A;
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1676-1685. PubMed ID: 36639249
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Does the Genetic Cause of Prader-Willi Syndrome Explain the Highly Variable Phenotype?
    Dobrescu AI; Chirita-Emandi A; Andreescu N; Farcas S; Puiu M
    Maedica (Bucur); 2016 Sep; 11(3):191-197. PubMed ID: 28694852
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Blended Phenotype of Prader-Willi Syndrome and HSP-
    Kunta AR; Jueng J; Jordan C; Kojic J; Mo A; Ebrahimi-Fakhari D
    Neurol Genet; 2022 Dec; 8(6):e200041. PubMed ID: 36524102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.